Phase I Study of EKB-569, an Irreversible Inhibitor of the...

Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

Erlichman, C., Hidalgo, M., Boni, J. P., Martins, P., Quinn, S. E., Zacharchuk, C., Amorusi, P., Adjei, A. A., Rowinsky, E. K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2005.01.8960
Date:
April, 2006
File:
PDF, 390 KB
english, 2006
Conversion to is in progress
Conversion to is failed